Automatic washing of thawed haematopoietic progenitor cell grafts: a preclinical evaluation

Autor:	Jean-Daniel Tissot, Stefano Barelli, Mélanie Abonnenc, B. Pesse, N. Lion
Rok vydání:	2017
Předmět:	medicine.medical_specialty Cryoprotectant Cell Survival 030204 cardiovascular system & hematology Hydroxyethyl starch Cryopreservation Hydroxyethyl Starch Derivatives Andrology 03 medical and health sciences Cryoprotective Agents 0302 clinical medicine medicine Humans Dimethyl Sulfoxide Progenitor cell business.industry Hematopoietic Stem Cell Transplantation Albumin Hematology General Medicine Hematopoietic Stem Cells Surgery Haematopoiesis Apheresis Blood Component Removal Ringer lactate business 030215 immunology medicine.drug
Zdroj:	Vox Sanguinis. 112:367-378
ISSN:	0042-9007
Popis:	Background and Objectives Autologous haematopoietic progenitor cell (HPC) is a prerequisite for high-dose chemotherapy in treatment of several haematologic and non-haematologic malignancies. HPCs are collected by apheresis and cryopreserved until infusion. Postinfusion adverse events have been in part related to the dimethyl sulphoxide (DMSO) used as cryoprotectant. The aim was to evaluate (i) an automated sequential washing procedure for DMSO removal in thawed HPC grafts and (ii) washing solutions in replacement of hydroxyethyl starch (HES)-based solutions. Materials and Methods A total of 26 HPC bags cryopreserved with 10% DMSO and intended for disposal were used. The Sepax-2 (Biosafe, Eysins, Switzerland) was evaluated using a sequential washing procedure. Outcomes were CD34+ cell recovery and viability after washing. Results The Ringer lactate supplemented or not with albumin 2·5–5% presented satisfactory results compared with HES solution in terms of CD34+ cell recovery and viability after washing. However, the apparition of aggregates led us to renounce to these alternative solutions. Using HES solution and a sequential washing of three bags, we showed the elimination of 95% of the DMSO, a postwash viable CD34+ cell recovery of 79·9 ± 9·4% and a total nucleated cell viability of 66·5 ± 9·3%. Conclusion The preclinical evaluation of an automated sequential washing procedure for DMSO removal in thawed HPC grafts has proven to be effective and comparable to previously published data. Despite our attempt to find an alternative solution to the HES solution, more efforts should be done on this side to reach a consensus on cryopreservation protocols.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14ed389c633ccb9358d1d61d0b38daef https://doi.org/10.1111/vox.12503 Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.